Natural Product: NPC553311

Natural Product IDNPC553311
Common Name
?
The InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
[(2~{R},3~{R},4~{R},5~{R},6~{R})-4,5-dihydroxy-2-methyl-6-[[(2~{R},3~{R},4~{S},5~{R},6~{S})-3,4,5-trihydroxy-6-[5-hydroxy-2-(4-methoxyphenyl)-4-oxo-chromen-7-yl]oxy-tetrahydropyran-2-yl]methoxy]tetrahydropyran-3-yl] acetate
IUPAC Name [(2~{R},3~{R},4~{R},5~{R},6~{R})-4,5-dihydroxy-2-methyl-6-[[(2~{R},3~{R},4~{S},5~{R},6~{S})-3,4,5-trihydroxy-6-[5-hydroxy-2-(4-methoxyphenyl)-4-oxo-chromen-7-yl]oxy-tetrahydropyran-2-yl]methoxy]tetrahydropyran-3-yl] acetate
Synonyms
Synthetic Gene Cluster n.a.
ChEMBL Identifier n.a.
PubChem CID n.a.
Chemical Classification
  • CHEMONTID:0000000 [Organic compounds]

The Chemical Classification was calculated by Classyfire, a software for chemical taxonomy calculation. Reference: DOI:10.1186/s13321-016-0174-y.

  Chemical Representations

Standard InCHIKey QZOBONFUOPKXNI-MIPSZYPSSA-N
Standard InCHI InChI=1S/C30H34O15/c1-12-28(42-13(2)31)25(36)27(38)29(41-12)40-11-21-23(34)24(35)26(37)30(45-21)43-16-8-17(32)22-18(33)10-19(44-20(22)9-16)14-4-6-15(39-3)7-5-14/h4-10,12,21,23-30,32,34-38H,11H2,1-3H3/t12-,21-,23+,24+,25-,26-,27-,28+,29-,30-/m1/s1
SMILES COC1=CC=C(C2=CC(=O)C3=C(O)C=C(O[C@@H]4O[C@H](CO[C@@H]5O[C@H](C)[C@H](OC(C)=O)[C@H](O)[C@H]5O)[C@H](O)[C@H](O)[C@H]4O)C=C3O2)C=C1

  Calculated Properties

Physi-Chem Properties

Molecular Weight:   634.19 Volume:   592.779
?
Van der Waals volume.
Dense:   1.07 LogP:   1.405
?
The logarithm of the n-octanol/water distribution coefficients.
logD7.4:   1.785
?
The logarithm of the n-octanol/water distribution coefficient at pH=7.4.
LogS:   -3.121
?
The logarithm of aqueous solubility value.
Rotatable Bonds:   9.0 Rigid Bonds:   31.0
TPSA:   224.04
?
Topological Polar Surface Area.
H-Bond Acceptor:   15.0
H-Bond Donor:   6.0 Rings:   5.0
Heavy Atoms:   15.0

MedChem Properties

QED Drug-Likeness Score:   0.176 GASA:   0.0
?
GASA represents the probability of being difficult to synthesize, ranging from 0 to 1.
Synthetic Accessibility Score:   4.669 Fsp3:   0.467
MCE-18:   117.455
?
MCE-18 stands for medicinal chemistry evolution.MCE-18≥45 is considered a suitable value.
Lipinski Rule-of-5:   Accepted
Pfizer Rule:   Rejected GSK Rule:   Accepted
Golden Triangle Rule:   Accepted BMS Rule:   0
Chelating Alert:   0 PAINS Alert:   0
Colloidal aggregators:   0.623 Fluc inhibitor:   0.318
?
The fluc inhibitor value is the probability of being fLuc inhibitors, within the range of 0 to 1.
Blue fluorescence:   0.902
?
The blue fluorescence value is the probability of being blue fluorescence, within the range of 0 to 1
Green fluorescence:   0.403
?
The green fluorescence value is the probability of being green fluorescence, within the range of 0 to 1
Reactive compounds:   0.062 Promiscuous compounds:   0.237

ADMET Properties (ADMETlab3.0)

ADMET: Absorption

Caco-2 Permeability:   -6.148 MDCK Permeability:   -5.225
Pgp-inhibitor:   0.001 Pgp-substrate:   0.911
PAMPA:   0.996
?
The experimental data for Peff was logarithmically transformed (logPeff). Molecules with log Peff values below 2.0 were classified as low-permeability (Category 0), while those with log Peff values exceeding 2.5 were classified as high-permeability (Category 1).
Human Intestinal Absorption (HIA):   0.996
20% Bioavailability (F20%):   0.971 30% Bioavailability (F30%):   1.0
50% Bioavailability (F50%):   1.0

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):   0.0 MRP1:   0.821
Plasma Protein Binding (PPB):   85.946% Volume Distribution (VD):   -0.168
Fu: 14.4%
?
The fraction unbound in plasms.
OATP1B1 inhibitor:   0.998
OATP1B3 inhibitor:   1.0 BCRP inhibitor:   0.282
BSEP inhibitor:   0.002

ADMET: Metabolism

CYP1A2-inhibitor:   0.0 CYP1A2-substrate:   0.0
CYP2C19-inhibitor:   0.0 CYP2C19-substrate:   0.0
CYP2C9-inhibitor:   0.0 CYP2C9-substrate:   0.0
CYP2D6-inhibitor:   0.0 CYP2D6-substrate:   0.004
CYP3A4-inhibitor:   0.0 CYP3A4-substrate:   0.005
CYP2B6-substrate:   0.0 CYP2C8-inhibitor:   1.0
HLM stability:   0.37
?
Human liver microsomal (HLM) stability. Category 0: stable+ (HLM > 30 min); Category 1: unstable- (HLM ≤ 30 min). The output value is the probability of human liver microsomal instability, where a value closer to 1 indicates a higher likelihood of instability.

ADMET: Excretion

Clearance (CL):  1.361 Half-life (T1/2):  2.305

ADMET: Toxicity

hERG Blockers:  0.018 hERG Blockers (10um):  0.083
Human Hepatotoxicity (H-HT):  0.579 Drug-induced Liver Injury (DILI):  0.998
AMES Toxicity:  0.995 Rat Oral Acute Toxicity:  0.062
Maximum Recommended Daily Dose:  0.059 Skin Sensitization:  0.999
Carcinogencity:  0.405 Eye Corrosion:  0.0
Eye Irritation:  0.264 Respiratory Toxicity:  0.065
Drug-induced Neurotoxicity:  0.012 Ototoxicity:  0.795
Hematotoxicity:  0.763 Drug-induced Nephrotoxicity:  0.784
Genotoxicity:  0.988 RPMI-8226 Immunitoxicity:  0.286
A549 Cytotoxicity:  0.95 Hek293 Cytotoxicity:  0.798
BCF:   0.408
?
Bioconcentration factors are used for considering secondary poisoning potential and assessing risks to human health via the food chain. The unit is -log10[(mg/L)/(1000*MW)].
IGC50:   3.172
?
48 hour Tetrahymena pyriformis IGC50. The unit of IGC50 is -log10[(mg/L)/(1000*MW)].
LC50DM:   4.678
?
48 hour Daphnia magna LC50. The unit of LC50DM is -log10[(mg/L)/(1000*MW)].
LC50FM:   3.874
?
96 hour fathead minnow LC50. The unit of LC50FM is -log10[(mg/L)/(1000*MW)].

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO58478 Thalictrum aquilegifolium Species Ranunculaceae Eukaryota n.a. n.a. n.a. Database[COCONUT]
NPO58982 Thalictrum przewalskii Species Ranunculaceae Eukaryota n.a. n.a. n.a. Database[COCONUT]

Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



  NP Quantity Composition/Concentration

Organism ID Organism Name Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



 Biological Activity

Molecular-level activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference

In vitro activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference

In vivo activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference





 Experimental ADME

Experiment Model Experiment Tissue ADME Type ADME Relation ADME Value ADME Unit Reference





 Experimental Toxicity

Quantitative toxicity

Experiment Model Experiment Organism Toxicity Type Toxicity Relation Toxicity Value Toxicity Unit Reference

Common Abbreviations:
LC: Lethal Concentration; LD: Lethal Dose; LT:Lethal Time; NOAEL: No-observed-adverse-effect Level; BMDL: Benchmark Dose Lower Confidence Limit; BMD: Benchmark Dose; BMC:Benchmark Concentration; LOAEL: Lowest Observed Adverse Effect Level; RfD:Reference Dose; RfC:Reference Concentration; MRL: Minimal Risk Level; MEG: Maximum Exposure Guideline; PAC: Protective Action Criteria

Categorical toxicity labels

Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption
Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP toxicity records from domain-specific databases. These databases include:
ToxValDB: a curated database that compiles quantitative toxicity values for chemicals from diverse public sources to support toxicological research and risk assessment.
TOXRIC: a comprehensive, free-to-access, online database providing toxicological/feature data. The toxicity labels are retrieved from this database. [PMID: 36400569]


  Chemically structural similarity

Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes approximately 50,000 NPs with experimentally-derived bioactivity available in NPASS)

Similarity is measured using the Tanimoto coefficient (Tc) , which compares the binary fingerprints of two molecules. Tc is calculated as the intersection divided by the union of '1' bits in the fingerprints, ranging from 0 to 1, with 1 indicating highest similarity.

●  The left chart: Distribution of similarity level between NPC553311 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.5 or Top200).

Similarity Score Similarity Level Natural Product ID
1.0 High Similarity NPC488089
0.8256 Intermediate Similarity NPC22062
0.8256 Intermediate Similarity NPC473634
0.8256 Intermediate Similarity NPC138811
0.8105 Intermediate Similarity NPC488087
0.7917 Intermediate Similarity NPC488083
0.7889 Intermediate Similarity NPC473623
0.7475 Intermediate Similarity NPC488088
0.7312 Intermediate Similarity NPC209296
0.7143 Intermediate Similarity NPC44931
0.7097 Intermediate Similarity NPC46202
0.7083 Intermediate Similarity NPC101636
0.6907 Remote Similarity NPC298171
0.6897 Remote Similarity NPC181712
0.6882 Remote Similarity NPC210073
0.6869 Remote Similarity NPC11468
0.6809 Remote Similarity NPC204693
0.6782 Remote Similarity NPC95090
0.6782 Remote Similarity NPC27408
0.663 Remote Similarity NPC211594
0.6571 Remote Similarity NPC488086
0.6429 Remote Similarity NPC483707
0.6364 Remote Similarity NPC262222
0.6346 Remote Similarity NPC473644
0.6327 Remote Similarity NPC65711
0.6286 Remote Similarity NPC311850
0.6262 Remote Similarity NPC68592
0.6237 Remote Similarity NPC220169
0.6224 Remote Similarity NPC64051
0.6146 Remote Similarity NPC295613
0.6146 Remote Similarity NPC473657
0.6139 Remote Similarity NPC479765
0.6129 Remote Similarity NPC80188
0.61 Remote Similarity NPC229409
0.6087 Remote Similarity NPC27942
0.604 Remote Similarity NPC479766
0.604 Remote Similarity NPC270675
0.604 Remote Similarity NPC195685
0.6 Remote Similarity NPC331652
0.598 Remote Similarity NPC475382
0.5957 Remote Similarity NPC22832
0.5957 Remote Similarity NPC243930
0.5943 Remote Similarity NPC472993
0.5938 Remote Similarity NPC172807
0.5922 Remote Similarity NPC470449
0.5895 Remote Similarity NPC607707
0.5865 Remote Similarity NPC470446
0.5865 Remote Similarity NPC472994
0.5833 Remote Similarity NPC190003
0.5761 Remote Similarity NPC39360
0.5761 Remote Similarity NPC19709
0.5761 Remote Similarity NPC29763
0.5761 Remote Similarity NPC210003
0.5758 Remote Similarity NPC67105
0.5743 Remote Similarity NPC475366
0.5714 Remote Similarity NPC254540
0.57 Remote Similarity NPC473512
0.57 Remote Similarity NPC129827
0.5652 Remote Similarity NPC473043
0.5644 Remote Similarity NPC186816
0.5625 Remote Similarity NPC298666
0.5625 Remote Similarity NPC198199
0.5625 Remote Similarity NPC608742
0.5614 Remote Similarity NPC120952
0.56 Remote Similarity NPC227508
0.5567 Remote Similarity NPC311830
0.5566 Remote Similarity NPC135358
0.5556 Remote Similarity NPC29353
0.5532 Remote Similarity NPC189142
0.5532 Remote Similarity NPC77660
0.5474 Remote Similarity NPC186807
0.5446 Remote Similarity NPC275454
0.5437 Remote Similarity NPC284277
0.5437 Remote Similarity NPC475497
0.5426 Remote Similarity NPC58053
0.5426 Remote Similarity NPC261866
0.5392 Remote Similarity NPC303913
0.5306 Remote Similarity NPC601144
0.5278 Remote Similarity NPC179862
0.5243 Remote Similarity NPC479405
0.5234 Remote Similarity NPC477629
0.5196 Remote Similarity NPC187379
0.5192 Remote Similarity NPC479404
0.5146 Remote Similarity NPC15358
0.5104 Remote Similarity NPC143851
0.5096 Remote Similarity NPC65003
0.5094 Remote Similarity NPC479403
0.5051 Remote Similarity NPC611303
0.5047 Remote Similarity NPC606657

Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC553311 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.5 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.7312 Intermediate Similarity NPD7054 Phase 4
0.5607 Remote Similarity NPD7472 Pre-clinical
0.5321 Remote Similarity NPD7808 Phase 3
0.5234 Remote Similarity NPD7251 Phase 2

Bioactivity similarity

  Bioactivity similarity

Similar Natural Products in NPASS

Similarity level is defined by Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.
Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data